Lv3
220 积分 2022-03-16 加入
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial
2个月前
已完结
PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer
3个月前
已完结
Phase II, double-blind, randomized study of salvage radiation therapy (SRT) plus enzalutamide or placebo for high-risk PSA-recurrent prostate cancer after radical prostatectomy: The SALV-ENZA Trial
3个月前
已完结
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review
3个月前
已完结
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study
5个月前
已完结
Management of Bulky Inguinal and Pelvic Lymph Nodes
5个月前
已关闭
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review
1年前
已完结
Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
1年前
已完结
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes
1年前
已完结
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
1年前
已完结
皖公网安备34019202002308
